Induction of strong anti-HIV cellular immunity by a combination of clostridium perfringens expressing HIV gag and virus like particles

Current HIV Research

Volumn 9, Issue 8, 2011, Pages 613-622

  Pegu, Poonam ^a   Helmus, Ruth ^b   Gupta, Phalguni ^a   Tarwater, Patrick ^c   Caruso, Lori ^a   Shen, Chengli ^a   Ross, Ted ^d   Chen, Yue ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium perfringens; Gastrointestinal tract; HIV; Mucosal immunity; Mucosal vaccine; Virus like particles

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEIN P55; RECOMBINANT CLOSTRIDIUM PERFRINGENS EXPRESSING HIV1 GAG PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; INTERMETHOD COMPARISON; LAMINA PROPRIA; MOUSE; NONHUMAN; PEYER PATCH; VACCINATION; VIRUS LIKE AGENT;

ADMINISTRATION, ORAL; AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLOSTRIDIUM PERFRINGENS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GASTROINTESTINAL DISEASES; GENETIC VECTORS; HIV; HIV INFECTIONS; IMMUNITY, CELLULAR; MICE; MUCOUS MEMBRANE;

EID: 84863038353     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211798998808     Document Type: Article

References (42)

1. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11(4 Suppl): S45-53.
2. Ogra PL, Faden H, Welliver RC: Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14(2): 430-45.
3. Quiding M, Nordstrom I, Kilander A, etal. Intestinal immune responses in humans: Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest 1991; 88(1): 143-8.
4. Johansson EL, Wassen L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69(12): 7481-6.
5. Belyakov IM, Berzofsky JA. Immunobiology of mucosal hiv infection and the basis for development of a new generation of mucosal aids vaccines. Immunity 2004; 20(3): 247-53.
6. Kiyono H, Fukuyama S: Nalt-versus peyer's-patch-mediated mucosal immunity. Nat Rev Immunol (2004) 4(9):699-710.
7. Lieberman J, Frankel FR. Engineered listeria monocytogenes as an aids vaccine. Vaccine 2002; 20(15): 2007-10.
8. Shata MT, Reitz MS Jr, DeVico AL, Lewis GK, Hone DM. Mucosal and systemic hiv-1 env-specific cd8(+) t-cells develop after intragastric vaccination with a salmonella env DNA vaccine vector. Vaccine 2001; 20(3-4): 623-9.
9. Helmus RA, Poonam P, Caruso L, Gupta P, Chen Y. Induction of siv p27-specific multifunctional t cells in the gut following prime-boost immunization with clostridium perfringens and adenovirus vaccines expressing siv p27. Curr HIV Res 2010; 8(2): 101-12.
10. Zhao Y, Melville SB: Identification and characterization of sporulationdependent promoters upstream of the enterotoxin gene (cpe) of clostridium perfringens. J Bacteriol 1998; 180(1): 136-42.
11. Chen Y, Helmus R, McClane B, et al. Use of a clostridium perfringens vector to express high levels of siv p27 protein for the development of an oral siv vaccine. Virology 2004; 329(2): 226-33.
12. Doan LX, Li M, Chen C, Yao Q. Virus-like particles as hiv-1 vaccines. Rev Med Virol 2005; 15(2): 75-88.
13. Johnson RP: Mechanisms of protection against simian immunodeficiency virus infection. Vaccine 2002; 20(15): 1985-7.
14. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of cd4+ t cell depletion and viral replication in siv infection. Science 1998; 280(5362): 427-31.
15. Young KR, Smith JM, Ross TM. Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology 2004; 327(2): 262-72.
16. Guerrero RA, Ball JM, Krater SS, Pacheco SE, Clements JD, Estes MK. Recombinant norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 2001; 75(20): 9713-22.
17. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus l1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992; 89(24): 12180-4.
18. Belyakov IM, Derby MA, Ahlers JD, etal. Mucosal immunization with hiv-1 peptide vaccine induces mucosal and systemic cytotoxic t lymphocytes and protective immunity in mice against intrarectal recombinant hiv-vaccinia challenge. Proc Natl Acad Sci U S A 1998; 95(4): 1709-14.
19. Vuola JM, Keating S, Webster DP, et al. Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers. J Immunol 2005; 174(1): 449-55.
20. Brenchley JM, Schacker TW, Ruff LE, et al. Cd4+ t cell depletion during all stages of hiv disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200(6): 749-59.
21. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1(1): 23-30.
22. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory cd4+ t cells in multiple tissues during acute siv infection. Nature 2005; 434(7037): 1093-7.
23. Genesca M, Skinner PJ, Bost KM, etal. Protective attenuated lentivirus immunization induces siv-specific t cells in the genital tract of rhesus monkeys. Mucosal Immunol 2008; 1(3): 219-28.
24. Genesca M, Skinner PJ, Hong JJ, et al. With minimal systemic t-cell expansion, cd8+ t cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus shiv89.6 from vaginal challenge with simian immunodeficiency virus. J Virol 2008; 82(22): 11181-96.
25. Xin KQ, Hoshino Y, Toda Y, et al. Immunogenicity and protective efficacy of orally administered recombinant lactococcus lactis expressing surface-bound HIV env. Blood 2003; 102(1): 223-8.
26. Chen LM, Briones G, Donis RO, Galan JE: Optimization of the delivery of heterologous proteins by the salmonella enterica serovar typhimurium type iii secretion system for vaccine development. Infect Immun 2006; 74(10): 5826-33.
27. Tsunetsugu-Yokota Y, Ishige M, Murakami M. Oral attenuated salmonella enterica serovar typhimurium vaccine expressing codonoptimized hiv type 1 gag enhanced intestinal immunity in mice. AIDS Res Hum Retroviruses 2007; 23(2): 278-86.
28. Rayevskaya MV, Frankel FR. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus gag protein in mice by a new hyperattenuated strain of listeria monocytogenes. J Virol 2001; 75(6): 2786-91.
29. Shata MT, Hone DM. Vaccination with a shigella DNA vaccine vector induces antigen-specific cd8(+) t cells and antiviral protective immunity. J Virol 2001; 75(20): 9665-70.
30. Vecino WH, Morin PM, Agha R, Jacobs WR Jr, Fennelly GJ. Mucosal DNA vaccination with highly attenuated shigella is superior to attenuated salmonella and comparable to intramuscular DNA vaccination for t cells against HIV. Immunol Lett 2002; 82(3): 197-204.
31. Frankel FR, Hegde S, Lieberman J, Paterson Y: Induction of cellmediated immune responses to human immunodeficiency virus type 1 gag protein by using listeria monocytogenes as a live vaccine vector. J Immunol 1995; 155(10): 4775-82.
32. Amara RR, Villinger F, Altman JD, et al. Control of a mucosal challenge and prevention of aids by a multiprotein DNA/mva vaccine. Science 2001; 292(5514): 69-74.
33. Rogers WO, Baird JK, Kumar A, et al. Multistage multiantigen heterologous prime boost vaccine for plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect Immun 2001; 69(9): 5565-72.
34. Schneider J, Langermans JA, Gilbert SC, et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus ankara induces strong cellular immune responses against the plasmodium falciparum trap antigen in chimpanzees. Vaccine 2001; 19(32): 4595-602.
35. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol; 2003 3(4): 331-41.
36. Shreedhar VK, Kelsall BL, Neutra MR. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to t-and b-cell areas of peyer's patches. Infect Immun 2003; 71(1): 504-9.
37. Anosova NG, Chabot S, Shreedhar V, Borawski JA, Dickinson BL, Neutra MR: Cholera toxin, e. Coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of peyer's patches. Mucosal Immunol 2008; 1(1): 59-67.
38. Kotton CN, Lankowski AJ, Scott N, et al. Safety and immunogenicity of attenuated salmonella enterica serovar typhimurium delivering an HIV-1 gag antigen via the salmonella type iii secretion system. Vaccine 2006; 24(37-39): 6216-24.
39. Peters C, Paterson Y: Enhancing the immunogenicity of bioengineered listeria monocytogenes by passaging through live animal hosts. Vaccine 2003; 21(11-12): 1187-94.
40. Baig J, Levy DB, McKay PF, et al. Elicitation of simian immunodeficiency virus-specific cytotoxic t lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination. J Virol 2002; 76(22): 11484-90.
41. Li Z, Zhang M, Zhou C, Zhao X, Iijima N, Frankel FR. Novel vaccination protocol with two live mucosal vectors elicits strong cellmediated immunity in the vagina and protects against vaginal virus challenge. J Immunol 2008; 180(4): 2504-13.
42. Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Berzofsky JA. A novel functional ctl avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal cd4+ t cells. J Immunol 2007; 178(11): 7211-21.